This inventor holds 1 USPTO granted patent. Top assignee: Oxford Gene Systems Limited. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: The Innovations of Elizabeth-Jane C Mellor
Introduction
Elizabeth-Jane C Mellor is a notable inventor based in Oxford, GB. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. His work has implications for vaccine development and diagnostic applications.
Latest Patents
Mellor holds a patent for a vector expressing fusion proteins. This patent describes fusion proteins that comprise a first amino acid sequence derived from a retrotransposon or an RNA retrovirus. The first amino acid sequence allows the fusion protein to assemble into particles, which can be utilized in vaccines or diagnostic and purification applications. The TYA gene of the yeast retrotransposon Ty codes for the first amino acid sequence, while the second amino acid sequence is a biologically active antigen.
Career Highlights
Mellor is associated with Oxford Gene Systems Limited, where he continues to advance his research and innovations. His work has garnered attention for its potential applications in the medical field.
Collaborations
Mellor has collaborated with notable colleagues, including Alan J Kingsman and Susan Mary Kingsman. Their combined expertise has contributed to the success of their projects and innovations.
Conclusion
Elizabeth-Jane C Mellor's contributions to the field of biotechnology through his patent on fusion proteins highlight his role as an influential inventor. His work continues to pave the way for advancements in vaccine development and diagnostic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile